Symbiosis opens contract injectables plant for early phase

“Our objective is to actively and aggressively drive down the amount of highly valuable drug development time”, Colin Mackay, Founder and CEORead the full story here :http://www.outsourcing-pharma.com/Contract-Manufacturing/Symbiosis-opens-contract-injectables-plant-for-early-phase

Get In Touch.


By ticking the box and clicking “Submit” below, you consent to receiving thought leadership, industry news, and invitations by email or other electronic means, which Symbiosis Pharmaceutical Services believes may be of value to you, relevant to your work and tailored to your professional profile and interests. This may include promotional information on products, services and events provided or organised by Symbiosis Pharmaceutical Services. By clicking the "Submit” button, you confirm that the information you have provided above is correct, and you agree to Symbiosis' processing of your personal data, including its transfer internationally and to third parties, in accordance with it's privacy policy.